Share-based Payment Arrangements | (3) Share-based Payment Arrangements As of September 26, 2020, the Company had two employee equity incentive plans, the 2002 employee stock option and stock incentive plan (the “ESOSIP”) and the 2011 equity incentive plan (the “2011 EIP”). No further grants can be made under the ESOSIP. The Company also has a stock compensation plan for members of its Board of Directors, the Amended and Restated 2013 Directors Stock Compensation Plan (as amended and restated as of May 17, 2016, the “2013 DSCP”). 6,000,000 shares of the Company’s common stock were Thirty Nine Weeks Ended Thirteen Weeks Ended September 26, 2020 September 28, 2019 September 26, 2020 September 28, 2019 Total cost of the Plans during the period $ 2,691 $ 4,470 $ 1,490 $ 1,102 Amount of related income tax benefit recognized during the period (1,618 ) (4,125 ) (483 ) (391 ) Net cost of the Plans during the period $ 1,073 $ 345 $ 1,007 $ 711 Included in income tax benefits recognized in the thirty-nine-week periods ended September 26, 2020 and September 28, 2019 were excess tax benefits from stock-based awards of $927,000 and $2,968,000, respectively. As of September 26, 2020, there were 60,586 shares of the Company’s common stock reserved for issuance under the 2013 DSCP and 3,675,862 shares of the Company’s common stock reserved for issuance in the aggregate under the ESOSIP and 2011 EIP. Restricted Stock Units The following table summarizes information regarding the Company’s outstanding restricted stock unit (“RSU”) awards with either a performance condition or a market condition under the Plans: Number of Weighted Average Grant Date Outstanding at December 28, 2019 198,875 $ 84.37 Granted 59,719 $ 102.62 Shares earned in excess of target (1) 11,648 $ 77.00 Vested shares, including shares earned in excess of target (76,290 ) $ 73.44 Forfeited (10,987 ) $ 100.55 Outstanding at September 26, 2020 182,965 $ 93.44 (1) Represents additional shares earned under the February 2, 2017 RSU awards as 2019 financial results exceeded target performance level. During the thirty-nine-week period ended September 26, 2020, the Company granted RSUs with a performance condition. Outstanding RSUs at both December 28, 2019 and September 26, 2020 include RSUs with a performance condition and RSUs with a market condition, as further described below and in the Company’s 2019 Annual Report on Form 10-K. RSUs with a performance condition granted on January 31, 2020 may vest on January 31 of 2023, 2024 and 2025 based on growth in operating income and pre-tax The Company recognized approximately $415,000 and $2,477,000 of share-based compensation expense related to RSU awards in the thirty-nine-week periods ended September 26, 2020 and September 28, 2019, respectively. As of September 26, 2020, there was a maximum of $34.6 million of total unrecognized compensation cost related to RSU awards granted under the Plans with an expected average remaining life of approximately 3.1 years. With respect to RSU awards with a performance condition, the amount of future compensation expense to be recognized will be determined based on future operating results. Stock Options The following table summarizes information regarding the Company’s outstanding stock options under the Plans: Number of Options Weighted Average per Share Weighted Average Remaining Term (years) Aggregate Intrinsic Value (000s) Options outstanding at December 28, 2019 44,467 $ 51.24 Exercised (23,717 ) $ 49.31 Options outstanding at September 26, 2020 20,750 $ 53.44 1.9 $ 1,499 Options exercisable at September 26, 2020 20,750 $ 53.44 1.9 $ 1,499 The total intrinsic value of stock options exercised during the thirty-nine-week periods ended September 26, 2020 and September 28, 2019 was $1,599,000 and $1,877,000, respectively. As of September 26, 2020, there was no unrecognized compensation cost related to stock options granted under the Plans. Non-vested The following table summarizes information regarding the Company’s outstanding shares of non-vested Number of Shares and Deferred Stock Weighted Average Grant Date Fair Value Non-vested 64,808 $ 98.24 Granted 26,604 $ 111.88 Vested (28,621 ) $ 98.83 Forfeited (2,351 ) $ 106.34 Non-vested 60,440 $ 103.65 The fair value of each share of non-vested As of September 26, 2020, there was $4,074,000 of total unrecognized compensation cost related to non-vested non-vested |